The pharmaceutical giant sold its flex building at the Imperial Center for $41.1 million to New York-based Lightstone Group, ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company's older drugs face ...

Florida's Medicaid Fraud Control Unit secured the win through a multistate action. "Actions, like those alleged here, must be stopped to prevent health care fraud." ...

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer CEO Albert Bourla told investors he dined with RFK Jr, a vaccine skeptic and nominee to head HHS. They discussed ...

Merck (MRK) stock sank like a stone on Tuesday after the pharmaceutical giant posted poor guidance for the rest of the year.

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...